Follow
Brooke E. Nichols
Title
Cited by
Cited by
Year
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical …
JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ...
The Lancet Global Health 2 (1), e23-e34, 2014
2162014
Sustainable HIV treatment in Africa through viral-load-informed differentiated care
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
1512015
Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study
BE Nichols, CAB Boucher, M van der Valk, BJA Rijnders, ...
The Lancet Infectious Diseases 16 (12), 1423-1429, 2016
992016
HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making
HIV Modelling Consortium Treatment as Prevention Editorial Writing Group
PLoS Medicine 9 (7), e1001259, 2012
962012
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models
DAMC Van De Vijver, BE Nichols, UL Abbas, CAB Boucher, V Cambiano, ...
Aids 27 (18), 2943-2951, 2013
892013
Population density and basic reproductive number of COVID-19 across United States counties
KTL Sy, LF White, BE Nichols
PloS one 16 (4), e0249271, 2021
792021
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
AN Phillips, V Cambiano, F Nakagawa, P Revill, MR Jordan, TB Hallett, ...
The lancet HIV 5 (3), e146-e154, 2018
662018
Effect of facility-based HIV self-testing on uptake of testing among outpatients in Malawi: a cluster-randomised trial
K Dovel, F Shaba, OA Offorjebe, K Balakasi, M Nyirenda, K Phiri, ...
The Lancet Global Health 8 (2), e276-e287, 2020
49*2020
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study
BE Nichols, CAB Boucher, JH van Dijk, PE Thuma, JL Nouwen, ...
PloS one 8 (3), e59549, 2013
442013
Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men
S Popping, SJ Hullegie, A Boerekamps, BJA Rijnders, RJ de Knegt, ...
PloS one 14 (1), e0210179, 2019
38*2019
Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study
BE Nichols, KCE Sigaloff, C Kityo, K Mandaliya, RL Hamers, ...
Aids 28 (1), 73-83, 2014
322014
Increasing the use of second‐line therapy is a cost‐effective approach to prevent the spread of drug‐resistant HIV: a mathematical modelling study
BE Nichols, KCE Sigaloff, C Kityo, RL Hamers, R Baltussen, S Bertagnolio, ...
Journal of the International AIDS Society 17 (1), 19164, 2014
302014
Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub‐Saharan Africa: a rapid systematic review
L Long, S Kuchukhidze, S Pascoe, BE Nichols, MP Fox, R Cele, ...
Journal of the International AIDS Society 23 (11), e25640, 2020
282020
Cost-effectiveness of PrEP in HIV/AIDS control in Zambia: a stochastic league approach
BE Nichols, R Baltussen, JH Van Dijk, PE Thuma, JL Nouwen, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (2), 221-228, 2014
272014
HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance
BE Nichols, CAB Boucher, D Van de Vijver
Journal of internal medicine 270 (6), 532-549, 2011
252011
Cardiovascular disease prevention policy in human immunodeficiency virus: recommendations from a modeling study
M Smit, RA van Zoest, BE Nichols, I Vaartjes, C Smit, M van der Valk, ...
Clinical Infectious Diseases 66 (5), 743-750, 2018
222018
Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa
Y Jo, L Jamieson, I Edoka, L Long, S Silal, JRC Pulliam, H Moultrie, ...
Open Forum Infectious Diseases 8 (3), ofab040, 2021
212021
Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
DAMC van de Vijver, AK Richter, CAB Boucher, ...
Eurosurveillance 24 (7), 1800398, 2019
212019
Monitoring viral load for the last mile: what will it cost?
BE Nichols, SJ Girdwood, T Crompton, L Stewart‐Isherwood, L Berrie, ...
Journal of the International AIDS Society 22 (9), e25337, 2019
202019
Partner notification for reduction of HIV-1 transmission and related costs among men who have sex with men: a mathematical modeling study
BE Nichols, HM Götz, ECM van Gorp, A Verbon, C Rokx, CAB Boucher, ...
PloS one 10 (11), e0142576, 2015
192015
The system can't perform the operation now. Try again later.
Articles 1–20